This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
Login Environment Pharma

SYNLAB pharma offers you standardized sampling kits

SYNLAB pharma delivers study-specific and visit-specific kits to each investigator in order to ensure appropriate and harmonized sample collections for each study.

Visit-specific kits include labels indicating study title and/or study ID, name of SPONSOR and/or CRO, type of visit, expiry date and any additional information as agreed in the Task Order. Each kit contains all standard lab material required plus needles, pipettes, security gloves, alcohol pads, and site-specific pre-printed airway bills for sample shipping.

Requisition forms are study and site specific. Kits are produced in compliance to GCP. Appropriate conformity of materials used for production of sample kits is documented (e.g. traceable material certificates). Content and expiry dates of each kit are documented by SYNLAB pharma. Re-supplies are organized by SYNLAB pharma according to SPONSOR/CRO's instructions.

Contact us


View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

Jun 18, 2018 | Pharma Continue
View All